Relapse and/or Refractory Multiple Myeloma
2 clinical trials · Condition
◉ Watch Relapse and/or Refractory Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma (NCT07726160) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-20 |
| A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal) (NCT04135963) | Takeda | 2020-07-31 |
Track Relapse and/or Refractory Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.